Supply Chain

The FDA found sterilizations issues at a Global Pharma facility, which manufactured eye drops contaminated with Pseudomonas aeruginosa, CNN reported April 3.

Emerge Manufacturing, a Cincinnati-based hospital manufacturing company, will break ground on its 50,000-square-foot, personal protective equipment manufacturing plant April 4. 

The Federal Trade Commission on April 3 ordered Illumina to divest cancer test maker Grail, saying the $7.1 billion deal would substantially stifle competition for cancer diagnostics in the U.S. 

The FDA is evaluating safety concerns with unapproved dental devices after receiving "reports of serious complications," the agency said March 30. 

On March 30, Medline opened its 650,000-square-foot distribution center in Hammond, La., after investing $72 million into the facility, according to a news release shared with Becker's. 

For Carlos Maceda, chief supply chain officer for Mount Sinai Health System in New York City, mentoring the next generation of supply chain leaders is a top priority.

Medical supply company Medline made a distribution agreement with a national purchasing organization to provide its products to up to 26,000 state agencies, counties, cities and school districts, Medline said March 28. 

With the COVID-19 public health emergency set to expire May 11, the FDA is preparing to prevent any supply disruptions to medical devices after three years of shortages partly spurred by the pandemic. 

Here are six FDA recalls, approvals and warnings Becker's has covered since Feb. 24:

Tune in and learn about the importance of healthcare providers reexamining their inventory management approaches in a dynamic environment. Terry Schwarzenbach shares insights into this process for health systems after periods of critical supply shortages and more. This episode is…